Sastasundar Ventures - Health X Platform Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Sastasundar Ventures - Health X Platform Share Price

278.40-8.11 (-2.83%)

Closed
As On: 11 Jun, 2026, 03:42 PM IST
As On: 11 Jun, 2026, 03:40 PM IST

Sector: Financial Servi...
Industry: Financial Services...

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	286.50
High	286.50
Low	274.20
Prev Close	286.50
Volume	12,637
VWAP(₹)	280.38

Key Metrics

PE Ratio(x)	753.13
EPS - TTM(₹)	0.37
MCap(₹ Cr.)	885.60
MCap Rank	57
PB Ratio(x)	1.19
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	363.00
52W Low(₹)	252.50
MCap/Sales	0.63
Beta(1 Month)	0.07
BV/Share(₹)	240.57

Sastasundar Ventures share price insights

Undertaking New Debt
Company has outstanding debt obligations for the first time in last 5 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 17.66% outperformed its 3 year CAGR of 8.91%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 6.36% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Sastasundar Ventures Share Price Update
Health X Platform Ltd. share price moved down by -2.83% from its previous close of Rs 286.50. Health X Platform Ltd. stock last traded price is 278.40
Share Price Value
Today/Current/Last 278.40279.25
Previous Day 286.50286.90

Found Insights useful?

Sastasundar Ventures Share Price Returns

1 Day	-2.83%
1 Month	-5.63%
3 Months	-1.45%
1 Year	-2.38%
3 Years	-4.02%
5 Years	15.21%

Sastasundar Ventures Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Sastasundar Ventures Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	387.54	359.35	306.83	323.81	307.47
Total Income Growth (%)	7.84	17.12	-5.24	5.32	14.10
Total Expenses	401.88	358.27	325.43	293.54	312.09
Total Expenses Growth (%)	12.17	10.09	10.87	-5.94	1.11
EBIT	-14.34	1.09	-18.60	30.27	-4.62
EBIT Growth (%)	-1,417.42	-	-161.44	-	-
Profit after Tax (PAT)	-11.17	1.13	-12.69	23.91	13.67
PAT Growth (%)	-1,088.87	-	-153.09	74.90	-
EBIT Margin (%)	-3.70	0.30	-6.06	9.35	-1.50
Net Profit Margin (%)	-2.88	0.31	-4.14	7.38	4.45
Basic EPS (₹)	-3.51	0.35	-3.99	7.52	4.30

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	0.19	0.11	0.11	0.35	0.30
Total Income Growth (%)	78.28	-5.11	-68.43	17.68	-0.43
Total Expenses	0.34	0.52	0.39	0.41	0.37
Total Expenses Growth (%)	-33.93	31.78	-4.02	11.54	-9.42
EBIT	-0.15	-0.41	-0.28	-0.05	-0.07
EBIT Growth (%)	-	-	-	-	-
Profit after Tax (PAT)	-0.15	-0.41	-0.28	-0.11	-0.07
PAT Growth (%)	-	-	-	-	-
EBIT Margin (%)	-80.51	-387.06	-250.72	-15.36	-21.70
Net Profit Margin (%)	-80.51	-387.06	-250.72	-30.98	-22.74
Basic EPS (₹)	-0.05	-0.13	-0.09	-0.03	-0.02

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,377.54	1,170.80	1,436.12	1,063.46	643.06
Total Revenue Growth (%)	17.66	-18.48	35.04	65.37	16.58
Total Expenses	1,378.77	1,173.03	1,380.44	1,092.85	685.88
Total Expenses Growth (%)	17.54	-15.03	26.32	59.34	20.75
Profit after Tax (PAT)	1.18	-91.17	8.88	-72.21	708.51
PAT Growth (%)	-	-1,126.34	-	-110.19	-
Operating Profit Margin (%)	-0.03	-0.18	4.12	-2.74	-6.52
Net Profit Margin (%)	0.08	-8.20	0.64	-6.94	112.20
Basic EPS (₹)	0.37	-28.66	2.79	-22.70	222.73

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	0.76	1.20	1.18	2.25	0.92
Total Revenue Growth (%)	-36.85	1.83	-47.46	145.71	-4.78
Total Expenses	1.71	1.92	2.07	1.60	1.25
Total Expenses Growth (%)	-10.74	-7.60	29.74	27.71	13.69
Profit after Tax (PAT)	-0.95	-0.71	-0.89	0.65	-0.39
PAT Growth (%)	-	-	-237.41	-	-
Operating Profit Margin (%)	-238.36	-173.71	0.00	0.00	0.00
Net Profit Margin (%)	-253.04	-176.65	0.00	0.00	0.00
Basic EPS (₹)	-0.30	-0.22	-0.28	0.20	-0.12

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 17.66% outperformed its 3 year CAGR of 8.91%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 6.36% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	935.77	974.37	1,149.59	1,205.82	1,277.80
Total Assets Growth (%)	-3.96	-15.24	-4.66	-5.63	336.69
Total Liabilities	170.50	109.84	150.06	212.26	70.31
Total Liabilities Growth (%)	55.23	-26.80	-29.30	201.87	11.19
Total Equity	765.27	864.53	999.53	993.56	1,207.48
Total Equity Growth (%)	-11.48	-13.51	0.60	-17.72	426.43
Current Ratio (x)	5.19	9.18	15.51	12.60	24.93
Total Debt to Equity (x)	0.03	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	3.53	3.87	2.48	3.76

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	271.02	272.16	272.93	273.85	273.11
Total Assets Growth (%)	-0.42	-0.28	-0.34	0.27	-0.15
Total Liabilities	0.16	0.35	0.39	0.43	0.30
Total Liabilities Growth (%)	-54.29	-10.26	-9.30	43.33	11.11
Total Equity	270.86	271.81	272.54	273.42	272.81
Total Equity Growth (%)	-0.35	-0.27	-0.32	0.22	-0.16
Current Ratio (x)	5,647.48	991.09	916.76	683.67	1,039.98
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	1.86	1.11	22.11	22.11

All figures in Rs Cr, unless mentioned otherwise

Insights

Undertaking New Debt
Company has outstanding debt obligations for the first time in last 5 years. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-73.83	-17.31	38.17	-104.50	-331.00
Net Cash used in Investing Activities	171.19	-1.13	-33.93	124.08	343.39
Net Cash flow from Financing Activities	-79.59	-0.44	-2.35	-0.87	-11.42
Net Cash Flow	17.77	-18.89	1.89	18.72	0.96
Closing Cash & Cash Equivalent	30.19	12.42	33.61	31.72	13.01
Closing Cash & Cash Equivalent Growth (%)	143.05	-63.04	5.95	143.91	8.00
Total Debt/ CFO (x)	-0.30	0.00	0.00	0.00	0.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	0.04	-5.51	-1.21	-0.63	-4.52
Net Cash used in Investing Activities	-0.01	5.45	1.09	0.64	4.54
Net Cash flow from Financing Activities	-	-	-	-	-
Net Cash Flow	0.03	-0.06	-0.11	0.02	0.02
Closing Cash & Cash Equivalent	0.05	0.03	0.08	0.20	0.18
Closing Cash & Cash Equivalent Growth (%)	105.36	-69.15	-57.19	9.90	12.45
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	0.18	-13.60	1.16	-9.58	78.01
Return on Capital Employed (%)	-0.05	-0.22	5.22	-2.54	-3.34
Return on Assets (%)	0.12	-9.35	0.77	-5.98	55.44
Interest Coverage Ratio (x)	7.87	17.56	65.23	-23.42	-22.63
Asset Turnover Ratio (x)	1.38	1.05	1.17	0.84	-
Price to Earnings (x)	714.29	-8.47	108.70	-9.71	1.60
Price to Book (x)	1.30	1.15	1.27	0.93	1.25
EV/EBITDA (x)	153.93	250.15	17.51	-36.68	-32.96
EBITDA Margin (%)	0.46	0.34	4.78	-1.95	-5.86

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-0.35	-0.26	-0.32	0.23	-0.14
Return on Capital Employed (%)	-0.33	-0.25	-0.32	0.24	-0.11
Return on Assets (%)	-0.35	-0.26	-0.32	0.23	-0.14
Interest Coverage Ratio (x)	-14.49	-50.73	-39.84	53.78	-10.61
Asset Turnover Ratio (x)	0.00	0.00	0.00	-	-
Price to Earnings (x)	-909.09	-1,111.11	-1,111.11	1,111.11	-3,333.33
Price to Book (x)	3.07	2.84	3.54	2.56	4.16
EV/EBITDA (x)	-1,039.10	-1,278.51	-1,254.29	851.05	-7,741.60
EBITDA Margin (%)	-212.74	-149.43	0.00	0.00	0.00

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Sastasundar Ventures	753.13	1.16	0.18	-0.05	0.12	8.91	-0.03	-0.10	0.37	5.19	0.03	-0.30
Crest Ventures	21.64	0.79	3.58	5.24	2.43	-37.16	53.15	29.79	16.61	5.83	0.21	6.05
Wealth First Portfolio Managers	25.10	5.71	25.69	30.28	21.48	33.77	75.63	55.98	36.29	5.79	0.00	0.00
Capital India Fin	23.23	1.31	5.77	1.99	2.10	-6.68	2.68	5.85	1.00	1.51	1.43	-3.78
Arihant Capital	21.58	1.54	7.13	14.08	2.86	14.27	30.83	15.11	2.87	1.63	0.54	-1.97
Add More

Annual Ratios (%)

Choose from Peers

Oswal Green Tech
NBI Industrial
CSL Finance
Mangal Credit
Nahar Capital

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 2,38,05,627 74.84 % 0.15
Pledge 0 0.00 % 0.00
FII 6,90,894 2.17 % -0.08
DII 8,26,498 2.60 % 0.53
MF 329 0.00 % 0.00
Others 64,87,481 20.39 % -0.60
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 74.84 74.69 74.24 74.24
Pledge 0.00 0.00 0.00 0.00
FII 2.17 2.25 2.03 1.89
DII 2.60 2.07 2.07 2.09
Mutual Funds 0.00 0.00 0.00 0.00
Others 20.39 20.99 21.66 21.78

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.01505401%
  % of AUM
- -3.39
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.00
  Amount Invested (in Cr.)
- 0.02%
  % of AUM
- 5.38
  % Change (MoM basis)

View all Mutual Fund Schemes

Sastasundar Ventures Top Searches

Corporate Actions

Recent
Board Meeting
Audited Results
May 22, 2026
Board Meeting
Quarterly Results
Jan 29, 2026
General Meeting
-
Jan 13, 2026

Announced on	Meeting on
May 22, 2026	May 30, 2026
Audited Results
Jan 29, 2026	Feb 06, 2026
Quarterly Results
Nov 03, 2025	Nov 13, 2025
Quarterly Results
Aug 04, 2025	Aug 12, 2025
Quarterly Results
May 22, 2025	May 30, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
May 23, 2012 Jul 23, 2012 10%
May 27, 2011 Jul 25, 2011 10%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Jan 13, 2026 Feb 15, 2026
-
Sep 01, 2025 Sep 26, 2025
-
Jul 17, 2025 Aug 20, 2025
-
Sep 09, 2024 Sep 30, 2024
A.G.M.
Feb 22, 2024 Mar 27, 2024
-

About Sastasundar Ventures

Health X Platform Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 911.37 Crore) operating in Financial Services sector.

Health X Platform Ltd. key Products/Revenue Segments include Interest for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 387.54 Crore, up 7.84 % from last quarter Total Income of Rs 359.35 Crore and up 26.04 % from last year same quarter Total Income of Rs 307.47 Crore. Company has reported net profit after tax of Rs -12.97 Crore in latest quarter.

The company’s top management includes Mr.Banwari Lal Mittal, Mrs.Abha Mittal, Mr.Ravi Kant Sharma, Mrs.Anjana Dikshit, Dr.J N Mukhopadhyaya, Mrs.Rupanjana De, Mr.Lokesh Agarwal, Mr.Pratap Singh. Company has JKVS & Co. as its auditors. As on 31-03-2026, the company has a total of 3.18 Crore shares outstanding.

Sastasundar Ventures Share Price Today is Rs. 278.40. On previous day, the Sastasundar Ventures Share Price (NSE) closed at Rs. 293.2, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 74.84% of the stake in Sastasundar Ventures shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Sastasundar Ventures stocks was 2.17% as compared to 2.25% in Dec 2025 with decrease of 0.08%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 2.6% as compared to 2.07% in Dec 2025 with increase of 0.53%. Out of the total DII holdings in Sastasundar Ventures shares 0.0% was held by mutual funds. The rest including public held is 20.39%. Sastasundar Ventures stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Sastasundar Ventures Dividend: Ever since 1989, Sastasundar Ventures dividends has been paid out around 2 times. As on 11 Jun, 2026, 03:42 PM IST, The overall dividend yield for Sastasundar Ventures stands at 0.0%. The last dividend paid was on July 25, 2011 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 0.37.

Sastasundar Ventures Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 387.54 Cr. of sales and 7.84% of quarterly net profit, there have been multiple ups and downs in the Sastasundar Ventures stock prices in the past few weeks. For example, Sastasundar Ventures stock price on 3rd of June 2026 was around Rs. 302.1. Sastasundar Ventures share price now stands at an average of Rs. 278.40. Judging by last week's performance, stock is in down trend.

Sastasundar Ventures has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Sastasundar Ventures share.

Historical Prices and Performance:
Sastasundar Ventures, incorporated in 1989 is a Small Cap company (with a market cap of Rs. 911.37) operating in Financial Services sector.
The Return of Equity (ROE) in last five financial years given by Sastasundar Ventures stock was 0.18%, -13.6%, 1.16%, -9.58% and 78.01% respectively.
The Sastasundar Ventures share gave a 3 year return of -1.22% as compared to Nifty 50 which gave a return of 25.06%.
Sastasundar Ventures announced 10.0% final dividend on July 25, 2011.

Key Metrics:
PE Ratio of Sastasundar Ventures is 775.04
Prices/Sales Ratio of Sastasundar Ventures is 0.63
Price/Book Ratio of Sastasundar Ventures is 1.19

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Sastasundar Ventures, major competitors and peers include Crest Ventures, Wealth First Portfolio Managers, Capital India Fin and Arihant Capital. As of Dec 2025, the dividend yield of Sastasundar Ventures stands at 0.0% while Crest Ventures, Wealth First Portfolio Managers, Capital India Fin and Arihant Capital stand at 0.26%, 1.42%, 0.0% and 0.78% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 775.04 and 1.19 respectively.

Leadership of Sastasundar Ventures :
Pratap Singh is Co. Secretary & Compl. Officer
Lokesh Agarwal is Chief Financial Officer
Banwari Lal Mittal is Chairman & Managing Director
Abha Mittal is Non Executive Director
Ravi Kant Sharma is Non Executive Director
Rupanjana De is Independent Director
J N Mukhopadhyaya is Independent Director
Anjana Dikshit is Independent Director

Show More

Industry

Financial Services - Misc

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap

Address

Azimganj House, 2nd Floor,Kolkata, West Bengal - 700017

Contact

investors@sastasundar.com

http://www.sastasundarventures.com

Executive Leadership

BL

Banwari Lal Mittal

Chairman & Managing Director

AM

Abha Mittal

Non Executive Director

RK

Ravi Kant Sharma

Non Executive Director

AD

Anjana Dikshit

Independent Director

Show More

Auditors

JKVS & Co.

Singhi & Co.

FAQs about Sastasundar Ventures share

1. What's the Sastasundar Ventures share price today?
Sastasundar Ventures share price is Rs 278.40 as on 11 Jun, 2026, 03:42 PM IST. Sastasundar Ventures share price is down by 2.83% based on previous share price of Rs 293.2. Sastasundar Ventures share price trend:
- Last 12 Months: Sastasundar Ventures share price moved down 2.38%
- Last 3 Years: Sastasundar Ventures Share price moved down by 4.02%
2. What is the market cap of Sastasundar Ventures?
Sastasundar Ventures share has a market capitalization of Rs 885.60 Cr. Within Financial Services sector, it's market cap rank is 57.
3. What is the PE & PB ratio of Sastasundar Ventures?
The PE ratio of Sastasundar Ventures stands at 775.04, while the PB ratio is 1.19.
4. What is 52 week high/low of Sastasundar Ventures share price?
52 Week high of Sastasundar Ventures share is Rs 363.00 while 52 week low is Rs 252.50
5. What are the returns for Sastasundar Ventures share?
Return Performance of Sastasundar Ventures Shares:
- 1 Week: Sastasundar Ventures share price moved down by 8.12%

Top Gainers

As on 03:59 PM | 11 Jun 2026

Aegis Logistics

925.90

124.90 (15.60%)

111.45

8.52 (8.28%)

DOMS Industries

2,255.40

136.81 (6.46%)

Blue Jet Healthcare

498.45

28.70 (6.11%)

1,923.80

90.80 (4.96%)

Top Losers

As on 03:59 PM | 11 Jun 2026

Balkrishna Ind.

1,974.00

-109.20 (-5.25%)

1,133.10

-60.31 (-5.06%)

155.70

-7.93 (-4.85%)

166.91

-8.00 (-4.57%)

Adani Transmission

1,466.70

-68.90 (-4.49%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.